TerminatedPhase 4

Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint

Stopped: The physician in charge is leaving the University of Florida

United States25 participantsStarted 2018-04-18

Plain-language summary

This study will examine the effectiveness of a single cortisone injection in patients with shoulder osteoarthritis over a 6-month period, and identify clinical and radiographic factors to help predict how a patient with shoulder osteoarthritis will respond to a cortisone injection utilizing ultrasound guidance.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with a diagnosis of symptomatic primary osteoarthritis of the shoulder will be recruited from the patient population seeking treatment at the Orthopaedics Sports Medicine Institute. * those who have failed previous treatment including over-the-counter analgesics and activity modification * have elected to receive a medically-indicated, ultrasound-guided IACSI in the shoulder. Exclusion Criteria: * Patients will be excluded from the study for any of the following reasons: * Post traumatic osteoarthritis * Inflammatory osteoarthritis * Imaging confirmed rotator cuff tear * Prior ipsilateral shoulder surgery * Memory loss or inability to complete study measures * History of allergy to injection medications * Diabetic patients with patient-reported fasting blood glucose \>200 * Prior injection in the ipsilateral shoulder within three months

What they're measuring

ASES Scores at Each Time Point

Timeframe: Baseline, 2 weeks, 1 month, 2 months, 3 months, 6 months

Visual Analog Scale Scores at Each Time Point.

Timeframe: Baseline, post-injection (5-10 minutes), 2 weeks, 1 month, 2 months, 3 months, 6 months

SST (Simple Shoulder Test) Scores at Each Time Point

Timeframe: Baseline, 2 weeks, 1 month, 2 months, 3 months, 6 months

Trial details

NCT IDNCT03232749

SponsorUniversity of Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06-06

Results submitted2021-01-27

View on ClinicalTrials.gov More Osteoarthritis of the Glenohumeral Joint trials

Plain-language summary

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

ASES Scores at Each Time Point

Timeframe: Baseline, 2 weeks, 1 month, 2 months, 3 months, 6 months

Visual Analog Scale Scores at Each Time Point.

Timeframe: Baseline, post-injection (5-10 minutes), 2 weeks, 1 month, 2 months, 3 months, 6 months

SST (Simple Shoulder Test) Scores at Each Time Point

Timeframe: Baseline, 2 weeks, 1 month, 2 months, 3 months, 6 months